Abstract:Background: Recent neutral randomised clinical trials have created clinical equipoise for treating obstructive sleep apnoea (OSA) for managing cardiovascular risk. The importance of defining the links between OSA and cardiovascular disease is needed with the aim of advancing the robustness of future clinical trials. We aimed to define the clinical correlates and characterise surrogate cardiovascular markers in patients with acute coronary syndrome (ACS) and OSA. Method: Overall, 66 patients diagnosed with ACS were studied. Patients underwent an unattended polysomnogram after hospital discharge (median [interquartile range] 62 [37-132] days). The Epworth Sleepiness Scale, Berlin, and STOP-BANG questionnaires were administered. Surrogate measures of vascular structure and function, and cardiovascular autonomic function were conducted. Pulse wave amplitude drop was derived from the pulse oximetry signals of the overnight polysomnogram. Results: OSA (apnoea-hypopnea index [AHI] ≥5) was diagnosed in 94% of patients. Moderate-to-severe OSA (AHI≥15) was observed in 68% of patients. Daytime sleepiness (Epworth Sleepiness Scale ≥10) was reported in 17% of patients. OSA screening questionnaires were inadequate to identify moderate-to-severe OSA, with an area under the receiver operating characteristic curve of approximately 0.64. Arterial stiffness (carotid-femoral pulse wave velocity, 6.1 [5.2-6.8] vs 7.4 [6.6-8.6] m/s, p=0.002) and carotid intima-media thickness (0.8 [0.7-1.0] vs 0.9 [0.8-1.0] mm, p=0.027) was elevated in patients with moderate-to-severe OSA. After adjusting for age, sex and body mass index, these relationships were not statistically significant. No relationships were observed in other surrogate cardiovascular markers. Conclusions: A high prevalence of OSA in a mostly non-sleepy population with ACS was identified, highlighting a gross underdiagnosis of OSA among cardiovascular patients. The limitations of OSA screening questionnaires highlight the need for new models of OSA screening as part of cardiovascular risk management. A range of inconsistent abnormalities were observed in measures of vascular structure and function, and these appear to be largely explained by confounding factors. Further research is required to elucidate biomarkers for the presence and impact of OSA in ACS patients.

Salivary Biomarkers Indicate Obstructive Sleep Apnea Patients with Cardiovascular Diseases

The Association of Salivary Biomarkers with the Severity of Obstructive Sleep Apnea and Concomitant Hypertension

Research on Serum Amyloid A Protein Levels in Patients with Obstructive Sleep Apnea

Chromatography/Mass Spectrometry-Based Biomarkers in the Field of Obstructive Sleep Apnea

Circadian differences of salivary protein in non-snoring males

Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome

Altered Salivary Microbiota in Patients with Obstructive Sleep Apnea Comorbid Hypertension

Urinary metabolomic biomarkers predict early cardiovascular risk in moderate-to-severe obstructive sleep apnea

Clinical Utility of Biochemical Markers of Obstructive Sleep Apnea

Quantification of Circulating Cell-Free DNA in the Serum of Patients with Obstructive Sleep Apnea–Hypopnea Syndrome

Metabolomics Profiling for Obstructive Sleep Apnea and Simple Snorers

Plasma Expression of HIF‐1α As Novel Biomarker for the Diagnosis of Obstructive Sleep Apnea‐hypopnea Syndrome

Circulating markers of oxidative stress and risk of incident cardiovascular events in obstructive sleep apnea

Alterations of IGF-1, Complement C3 and Superoxide Dismutase in Patients with Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome.

Metabolomic profiles predict clinical severity in patients with obstructive sleep apnea-hypopnea syndrome

Influence of Obstructive Sleep Apnea hypopnea Syndrome on Cardiovascular Risk Factors

Association of CLDN molecules with sleep apnea hypopnea syndrome: new biomarker candidates

Discovery and Preclinical Validation of Proteomic Biomarkers in Saliva for Early Detection of Oral Squamous Cell Carcinomas.

Analysis of Salivary Microbiome and Its Association With Periodontitis in Patients With Obstructive Sleep Apnea

Relationship Between Monocyte to HDL Cholesterol Ratio and Concomitant Cardiovascular Disease in Chinese Han Patients with Obstructive Sleep Apnea.

Phenotypic Characterisation of Obstructive Sleep Apnoea in Acute Coronary Syndrome